Vascular endothelial markers, von willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: Comparison of primary renal disease

Clinica Chimica Acta

Volumn 299, Issue 1-2, 2000, Pages 65-75

  Hirano, Tsutomu ^a   Ookubo, Keiko ^b   Kashiwazaki, Koichi ^a   Tajima, Hiroto ^a   Yoshino, Gen ^c   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Primary renal disease; Thrombomodulin index; Vascular endothelial damage; Von Willebrand factor

Indexed keywords

CREATININE; MARKER; MEMBRANE PROTEIN; THROMBOMODULIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA;

AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; THROMBOMODULIN; VON WILLEBRAND FACTOR;

EID: 0033935529     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00274-6     Document Type: Article

References (25)

1. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 32:1989;219-226.
2. Deckert T., Kofored-Enevoldsen A., Norgaard K., Borch-Johnsen K., Feldt-Rasmussen B., Jensen T. Microalbuminuria: implications for micro- and macrovascular disease. Diabetes Care. 15:1992;1181-1191.
3. Jensen T., Borch-Johnsen K., Kofoed-Enevoldsen A., Deckert T. Coronary heart disease in young Type1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 30:1987;144-148.
4. De Cosmo S., Bacci S., Piras G.P., et al. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia. 40:1997;1191-1196.
5. Schmitz A., Vaeth M. Microalbuminuria: a major risk factor in type 2 diabetes. A 10 year follow-up study of 503 patients. Diabet Med. 5:1988;126-134.
6. Haller H. Postprandial glucose and vascular disease. Diabet Med. 14:1997;S50-56.
7. Jaffe E.A., Hoyer L.W. Nachman RL.: Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA. 71:1974;1906-1909.
8. Suffredini A.F., Harpel P.C., Parrillo J.E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 320:1989;1165-1172.
9. DeGroot P.G., Sixma J.J. Role of von Willebrand factor in the vessel wall. Sem Thromb Haemostas. 13:1987;416-424.
10. Takano S., Kimura S., Ohdama S., Aoki N. Plasma thrombomodulin in health and diseases. Blood. 76:1990;2024-2029.
11. Blann A.D., Taberner D.A. Annotation: A reliable marker of endothelial cell dysfunction: does it exist ? Br J Haematol. 90:1995;244-248.
12. Stehouwer C.D.A., Nauta J.J.P., Zeldenrust G.C., Hackeng W.H.L., Donker A.J.M., den Ottolander G.J.H. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 340:1992;319-323.
13. Jensen T. Increased plasma level of von Willebrand factor in Type1 (insulin-dependent) diabetic patients with incipient nephropathy. Br. Med. J. 298:1989;27-28.
14. Stehouwer C.D.A., Stroes E.S.G., Hackeng W.H.L., Mulder P.G.H., Den Ottolander G.J.H. Von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes. 40:1991;971-976.
15. Fioretto P., Stehouwer C.D.A., Mauer M., et al. Heterogenous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia. 41:1998;233-236.
16. Rinno H., Kuramoto T., Iijima T., Yagame M. Tomino. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy. J Clin Lab Anal. 10:1996;119-124.
17. Shimano H., Takahashi K., Kawakami M., et al. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus. Clin Chim Acta. 25:1994;89-96.
18. Tomura S., Nakamura Y., Deguchi F., et al. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorder in patients undergoing regular hemodialysis therapy. Thromb Res. 58:1990;413-419.
19. Mezzano D., Tagle R., Pais E., et al. Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure. Thromb Res. 88:1997;465-472.
20. Gris J-C., Branger B., Vecina F., Savadani B.L., Fourcade J., Schved J-F. Increaed cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int. 46:1994;807-813.
21. Aznar-Salatti J., Escolar G., Cases A., et al. Uraemic medium causes endothelial cell dysfunction characterized by an alteration of the properties of its subendothelial matrix. Nephrol Dial Transplant. 10:1995;2199-2204.
22. Kario K., Matsuo T., Kobayashi H., Matsuo M., Sakata T., Miyata T. Activation of factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol. 15:1995;1114-1120.
23. Oida K., Takai H., Maeda H., et al. Plasma thrombomodulin concentration in diabetes mellitus. Diabetes Res Clin Pract. 10:1990;193-196.
24. Stehouwer C.D.A., Zellenrath P., Polak B.C.P., et al. Von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal albumin excretion. Diabetlogia. 35:1992;555-559.
25. Plater M.E., Ford I., Dent M.T., Preston F.E., Ward J.D. Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function. Diabetologia. 39:1996;336-343.